Autonomix Medical, Common Stock Alpha and Beta Analysis

AMIX Stock   3.35  0.18  5.10%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Autonomix Medical, Common. It also helps investors analyze the systematic and unsystematic risks associated with investing in Autonomix Medical, over a specified time horizon. Remember, high Autonomix Medical,'s alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Autonomix Medical,'s market risk premium analysis include:
Beta
(0.42)
Alpha
(1.55)
Risk
13.33
Sharpe Ratio
(0.12)
Expected Return
(1.62)
Please note that although Autonomix Medical, alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Autonomix Medical, did 1.55  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Autonomix Medical, Common stock's relative risk over its benchmark. Autonomix Medical, Common has a beta of 0.42  . As returns on the market increase, returns on owning Autonomix Medical, are expected to decrease at a much lower rate. During the bear market, Autonomix Medical, is likely to outperform the market. At this time, Autonomix Medical,'s Book Value Per Share is fairly stable compared to the past year. Tangible Book Value Per Share is likely to rise to 10.96 in 2024, despite the fact that Enterprise Value Over EBITDA is likely to grow to (2.59).

Enterprise Value

1.52 Billion

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Autonomix Medical, Backtesting, Autonomix Medical, Valuation, Autonomix Medical, Correlation, Autonomix Medical, Hype Analysis, Autonomix Medical, Volatility, Autonomix Medical, History and analyze Autonomix Medical, Performance.

Autonomix Medical, Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Autonomix Medical, market risk premium is the additional return an investor will receive from holding Autonomix Medical, long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Autonomix Medical,. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Autonomix Medical,'s performance over market.
α-1.55   β-0.42

Autonomix Medical, expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Autonomix Medical,'s Buy-and-hold return. Our buy-and-hold chart shows how Autonomix Medical, performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Autonomix Medical, Market Price Analysis

Market price analysis indicators help investors to evaluate how Autonomix Medical, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Autonomix Medical, shares will generate the highest return on investment. By understating and applying Autonomix Medical, stock market price indicators, traders can identify Autonomix Medical, position entry and exit signals to maximize returns.

Autonomix Medical, Return and Market Media

The median price of Autonomix Medical, for the period between Thu, Sep 12, 2024 and Wed, Dec 11, 2024 is 11.7 with a coefficient of variation of 32.35. The daily time series for the period is distributed with a sample standard deviation of 3.52, arithmetic mean of 10.89, and mean deviation of 2.56. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Disposition of tradable shares by Smith Trent N. of Autonomix Medical, subject to Rule 16b-3
09/18/2024
2
Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment
09/26/2024
3
Autonomix Announces Reverse Stock Split
10/22/2024
4
Autonomix Medical, Inc. to Participate in a Virtual Investor What This Means Segment on Wednesday, October 30th
10/25/2024
5
Why Is Nao-Cap Neurology Focused Autonomix Medical Stock Trading Higher On Monday
10/28/2024
6
Autonomix Medical, Inc. Announces Pricing of 9.0 Million Underwritten Public Offering
11/22/2024
7
Autonomix Medical, Inc. Announces Closing of 10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option
11/25/2024
8
Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful ...
12/05/2024

About Autonomix Medical, Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Autonomix or other stocks. Alpha measures the amount that position in Autonomix Medical, Common has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2010 2023 2024 (projected)
PB Ratio972.555.755.46
Capex To Depreciation0.230.210.18
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Autonomix Medical, in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Autonomix Medical,'s short interest history, or implied volatility extrapolated from Autonomix Medical, options trading.

Build Portfolio with Autonomix Medical,

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Autonomix Stock Analysis

When running Autonomix Medical,'s price analysis, check to measure Autonomix Medical,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Autonomix Medical, is operating at the current time. Most of Autonomix Medical,'s value examination focuses on studying past and present price action to predict the probability of Autonomix Medical,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Autonomix Medical,'s price. Additionally, you may evaluate how the addition of Autonomix Medical, to your portfolios can decrease your overall portfolio volatility.